IAC States that Cape Verde Again Fails to Live Up to the Rule of Law

IAC issues statement about report from Sputnik

NEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) — The facts of the Saab case are clear and without dispute according to Sputnik media via their special report written by Sergio Pintado, https://mundo.sputniknews.com/20210909/extradicion-de-alex-saab-a-eeuu-haria-sonrojar-a-un-estudiante-de-derecho-1115885046.html

The headline of the report is telling, “Alex Saab’s extradition to the United States would make a law student blush.”

The report outlines the various steps in the diligent process on how Alex Saab’s defense team has vowed to continue to fight to ensure the Venezuelan diplomat is not extradited, however, should Alex Saab be extradited, states Sara Flounders, International Action Center Founder, Cape Verde needs to be remembered as a nation failing judicial standards. An innocent man has been detained without reasons and did not have access to medical attention for 448 days. The reputation of Cape Verde will continue from here on, as one with no respect for human rights and its own legal process.

Sputnik’s report highlights Saab’s lawyers conclusion that the fact that authorizing extradition to the United States is “the atoning death of the rule of law” for Cape Verde (Africa). Over the few months, it has been said by external international relations experts, that this case is “purely motivated by political interests according to an agenda dictated by Washington DC.” Stated by a source close to a high level judge in France, along with Russia’s and Iran’s foreign Ministries.

ECOWAS lead counsel, Femi Falana and his team described the Constitutional Court ruling as “extremely poorly drafted, poorly argued and legally inconsistent, which “would blush a law student.” “The instrumentalization of law for political purposes requires a certain talent that Cape Verdean judges seem to lack. In the absence of substantive arguments that can convince the reader otherwise, the sentence is presented in a form and with confusing and hermetic language. The result is legally deplorable,” he adds.

MEDIA CONTACT:
Sara Flounders
International Action Center
https://iacenter.org/
E-mail: iacenter@iacenter.org
Tel: +1 212-633-6646

PDF available: http://ml.globenewswire.com/Resource/Download/b9d2cb53-42fe-4f72-ad4d-61364a135d34

แพลตฟอร์มข้อมูล Delphix DevOps ได้รับการรับรองการผสานรวมจาก SAP ร่วมกับ SAP NetWeaver® และ SAP S/4HANA®

โซลูชันมอบการปฏิบัติตามข้อกำหนดของข้อมูล การป้องกัน Ransomware ให้กับลูกค้าผ่านการทำงานร่วมกันกับเทคโนโลยี SAP

REDWOOD CITY, Calif., Sept. 11, 2021 (GLOBE NEWSWIRE) — Delphix บริษัทข้อมูลชั้นนำในอุตสาหกรรมสำหรับ DevOps ประกาศในวันนี้ว่า Delphix DevOps Data Platform 6.0 ได้รับการรับรอง SAP ว่าสามารถผสานรวมกับ SAP NetWeaver® และ SAP S/4HANA® การผสานรวมนี้ช่วยให้องค์กรต่างๆ สามารถใช้ Delphix เพื่อปกปิดข้อมูลโดยอัตโนมัติเพื่อให้เป็นไปตามการปฏิบัติตามข้อกำหนดด้านความเป็นส่วนตัว ปกป้องข้อมูลจากการโจมตีของ Ransomware และส่งมอบข้อมูลเสมือนจริงที่มีประสิทธิภาพ เพื่อเร่งการเผยแพร่ SAP หรือฝึกอบรมปัญญาประดิษฐ์และโมเดลการเรียนรู้ของเครื่อง

“การรับรอง SAP ของเราช่วยเพิ่มความสามารถที่สำคัญในการเร่งการเปลี่ยนแปลงทางดิจิทัล พร้อมทั้งปรับปรุงความเป็นส่วนตัวและการรักษาความปลอดภัยของข้อมูล” Dan Graves, CTO ของ Delphix กล่าว “การโจมตีแบบ Ransomware นั้นมีการขโมยข้อมูลร่วมด้วยมากยิ่งขึ้น ซึ่งทำให้ข้อมูลของลูกค้าถูกเปิดเผย และละเมิดกฎหมายความเป็นส่วนตัว เช่น GDPR, CCPA และ HIPAA การปกปิดข้อมูลและการรักษาความปลอดภัยให้การส่งข้อมูลโดยอัตโนมัติ ได้กลายเป็นสิ่งจำเป็นสำหรับทุกบริษัท”

ศูนย์การรับรองและการผสานรวมกับ SAP (SAP ICC) ได้รับรองว่าซอฟต์แวร์การผสานรวมสำหรับ Delphix DevOps Data Platform 6.0 ได้ผสานรวมกับ SAP NetWeaver และ SAP S/4HANA โดยใช้เทคโนโลยีการผสานรวมมาตรฐาน การผสานรวมเหล่านี้ จะช่วยให้องค์กรสามารถใช้ Delphix เพื่อปกปิดข้อมูล SAP ผ่านเลเยอร์ API ที่ SAP รับรอง ธุรกิจที่ใช้โซลูชัน SAP ยังสามารถผสานรวมการทำงานอัตโนมัติของข้อมูลและการจำลองเสมือนของ Delphix เข้ากับความสามารถอื่นๆ ของ SAP ผ่าน API

“ในสภาพแวดล้อมที่มีการควบคุมอย่างเข้มงวด เราต้องการความสามารถในการปกป้องข้อมูลสำคัญของลูกค้า ขณะที่ยังส่งมอบความสามารถในแอปพลิเคชันทางธุรกิจของเรา โซลูชันการปกปิดข้อมูลของ Delphix ช่วยให้เราสามารถปกปิดข้อมูลในโซลูชัน SAP, Oracle Fusion HCM, Salesforce และแอปที่กำหนดเองได้ โครงการปกปิดข้อมูลนั้นใช้เวลาน้อยกว่า 20 วัน ช่วยให้เราสามารถตอบสนองความต้องการของธุรกิจ” Mathieu Guesdon หัวหน้าแผนกที่ Energir กล่าว

เกี่ยวกับ Delphix
Delphix เป็นบริษัทข้อมูลชั้นนำในอุตสาหกรรมสำหรับ DevOps

ข้อมูลนั้นสำคัญอย่างยิ่งต่อการทดสอบการเปิดตัวแอปพลิเคชัน การปรับให้ทันสมัย​ การปรับใช้ระบบคลาวด์ และโปรแกรม AI/ML เราจัดเตรียมแพลตฟอร์มข้อมูล DevOps แบบอัตโนมัติสำหรับแอปพลิเคชันระดับองค์กรทั้งหมด Delphix จะปกปิดข้อมูลเพื่อความเป็นส่วนตัว รักษาความปลอดภัยข้อมูลจาก Ransomware และมอบข้อมูลเสมือนจริงที่มีประสิทธิภาพสำหรับ CI/CD

แพลตฟอร์มของเราประกอบด้วย DevOps API ที่จำเป็นสำหรับการจัดเตรียม รีเฟรช ย้อนดู ผสานรวม และควบคุมเวอร์ชันของข้อมูล บริษัทชั้นนำ เช่น Choice Hotels, J.B.Hunt และ Fannie Mae ใช้ Delphix เพื่อเร่งการเปลี่ยนแปลงทางดิจิทัล สำหรับข้อมูลเพิ่มเติม โปรดไปที่ www.delphix.com หรือติดตามเราได้ที่ LinkedIn, Twitter และ Facebook

ข้อความใดๆ ในข่าวประชาสัมพันธ์ฉบับนี้ที่ไม่ใช่ข้อเท็จจริงในอดีตถือเป็นข้อความเชิงคาดการณ์เหตุการณ์ในอนาคตตามที่กำหนดไว้ในกฎหมายปฏิรูปการฟ้องร้องคดีหลักทรัพย์ส่วนบุคคลของสหรัฐอเมริกาปี 1995 ข้อความเชิงคาดการณ์เหตุการณ์ในอนาคตทั้งหมดนั้นมีความเสี่ยงและความไม่แน่นอนต่างๆ ที่ระบุไว้ในเอกสารที่ SAP ยื่นต่อสำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์แห่งสหรัฐอเมริกา ซึ่งรวมถึงรายงานประจำปีล่าสุดในแบบฟอร์ม 20-F ซึ่งอาจทำให้ผลลัพธ์ที่แท้จริงแตกต่างจากที่คาดการณ์ไว้อย่างมาก SAP เตือนผู้อ่านว่าไม่ควรเชื่อถือข้อความเชิงคาดการณ์เหตุการณ์ในอนาคตเหล่านี้มากเกินไป ซึ่ง SAP ไม่มีหน้าที่ในการอัปเดต และเป็นจริงเฉพาะในวันที่นั้นเท่านั้น

SAP และผลิตภัณฑ์และบริการอื่นๆ ของ SAP ที่กล่าวถึงในที่นี้ รวมทั้งโลโก้ที่เกี่ยวข้องนั้นเป็นเครื่องหมายการค้าหรือเครื่องหมายการค้าจดทะเบียนของ SAP SE ในเยอรมนีและประเทศอื่นๆ โปรดดู https:// www.sap.com/copyright สำหรับข้อมูลเครื่องหมายการค้าและประกาศเพิ่มเติม ชื่อผลิตภัณฑ์และบริการอื่นๆ ทั้งหมดที่กล่าวถึงเป็นเครื่องหมายการค้าของบริษัทนั้นๆ

สำหรับรายละเอียดเพิ่มเติม โปรดติดต่อ:

Aarthi Rayapura
ผู้อำนวยการ กองบรรณาธิการและเนื้อหา
aarthi.rayapura@delphix.com

Olives and Wine: Conagen Makes Accessible Antioxidant Hydroxytyrosol by Fermentation

Bedford, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) — Leveraging its robust phenolics platform, Conagen announced the expansion of the health ingredient portfolio of its commercial partner Blue California, with the successful scale-up and commercialization of the powerful natural antioxidant ingredient hydroxytyrosol.With its health-promoting properties, hydroxytyrosol is a phenylethanoid found in olives and wine. Most hydroxytyrosol is naturally found in the juice of olives, minorly in oil. Current hydroxytyrosol ingredients on the market are produced mainly through processed olive juice or are synthetic.

Conagen’s high-purity hydroxytyrosol is virtually colorless and odorless, making it ideal for formulating different products. The hydroxytyrosol is produced by using a cost-effective, sustainable natural fermentation process that has led to the filing of several patent applications, making it a preferred option compared to its olive juice concentrate and synthetic counterparts.

“Hydroxytyrosol is derived from one of our four small-molecule platforms.  The flexibility of our phenolics platform has enabled us to rapidly scale and commercialize hydroxytyrosol and other novel ingredients, highlighting our productive innovation engine and reliability as a strategic service partner,” said Vice President of Innovation, Casey Lippmeier, Ph.D. at Conagen.

Hydroxytyrosol has received increasing attention in the dietary supplement world due to its potent antioxidant and anti-inflammatory properties that contribute to the many health benefits of consuming olives. Preclinical and clinical studies demonstrate the positive effects of hydroxytyrosol on heart health and support healthy cholesterol levels.

“The Mediterranean diet is consistently rated as one of the healthiest diets, partially attributed to the use of olives,” Blue California’s Research, Science and Innovation Officer, Linda May-Zhang, Ph.D. “Hydroxytyrosol is one of the most potent antioxidants in olives, and research suggests the great promise of this molecule in healthy aging and potential immune support applications.”

In addition to immune health, emerging research suggests hydroxytyrosol supports heart health, metabolic health, bone health, brain health, and beauty.

Immune health will remain a top priority for consumers as 64% of global consumers are looking to improve their immunity over the next 12 months, reported by FMCG Gurus, Top Ten Trends for 2021, Dec. 2020.

“Conagen is unlocking unprecedented access to sustainable compounds which are only sparingly found in nature,” said Lippmeier. “We expect this and other related compounds will prove useful as cost-effective food or cosmetic ingredients or as additives to other products in which oxidation must be mitigated.”

Using precision fermentation, Conagen produces an extensive portfolio of ingredients, with a recent focus on phenolic antioxidants and natural preservatives such as Rosmarinic acid (Rosavel®)Capsaicin, and the recently announced p-Coumaric Acid (PCA). These ingredients add to a long list of health-promoting flavonoids such as Dihydroquercetin (DHQ), also known as Taxifolin.

Blue California is a provider of solutions and manufacturer/distributor of specialty ingredients, flavors, and fragrances and has a long-standing innovation partnership with Conagen. Conagen focuses on developing sustainable, nature-based ingredients that improve existing options in the market or represent completely novel ingredient solutions.

About Conagen

Conagen is a product-focused synthetic biology R&D company with large-scale manufacturing capabilities. Our scientists and engineers use the latest synthetic biology tools to develop high-quality, sustainable, nature-based products by precision fermentation and enzymatic bioconversion. We focus on the bioproduction of high-value ingredients for food, nutrition, flavors and fragrances, pharmaceutical, and renewable materials industries. www.conagen.com

About Blue California

Blue California is a vertically integrated technology company providing innovative ingredient solutions to global partners. With more than 20 years of innovation success, our ingredients are used in commercial products and applications in nutrition, personal care, healthy aging and wellness, functional food and beverage, and beauty. www.bluecal-ingredients.com

Attachment

Ana Arakelian
Conagen
+1.781.271.1588
ana.arakelian@conagen.com

FLEXIM Announces New Non-Intrusive and Intrinsically Safe Explosion-Proof Flowmeter

Non-intrusive and intrinsically safe Explosion-proof flowmeter for liquids, gases and steam

FLUXUS FG 831

BERLIN KÖPENICK, Germany, Sept. 10, 2021 (GLOBE NEWSWIRE) — With FLUXUS F/G831, FLEXIM presents the most advanced flow measurement technology for use in hazardous areas. The new ultrasonic system measures liquids, gases and steam and is approved for operation in ATEX/IECEx Zone 1. The flow measurement is carried out non-intrusively with ultrasonic transducers mounted on the outside of the pipe. FLUXUS F/G831 has two intrinsically safe (Ex-ia) process inputs for connecting pressure and temperature sensors. This allows the transmitter to directly determine the output mass flow or standard volumetric flow rate.

The new series of instruments has been specially developed for demanding measurement tasks in challenging environments. Inside the hermetically sealed enclosure, a digital signal processor ensures the highest measurement performance. The integrated disturbance correction ensures good measuring accuracy even at unfavourable measuring points. Furthermore, the high-performance processor supports fast switching between two measuring channels. Synchronized channel averaging enables immediate compensation of measured value fluctuations resulting from disturbances of the flow profile due to turbulence or difficult inlet conditions. As with all FLUXUS series flowmeters, the FLUXUS F/G831 ultrasonic transducers are carefully paired at the factory and have temperature compensation according to ANSI/ASME MFC 5M. Both form the basis for absolute zero-point stability and accurate bidirectional flow measurement over a very wide measuring range. At FLEXIM, transmitters and transducers are calibrated independently of each other in a patented process and without the influence of application-related disturbances. This always ensures the highest measuring accuracy in the field, regardless of the application the measuring system is used for.

FLUXUS F/G831 offers various protocols for bidirectional communication such as Modbus, Profibus, Foundation Fieldbus and HART. It also offers the option of parameterization and wireless transmission of measured values and internal diagnostic data via WLAN. With the FluxDiag software, the data can be conveniently visualized and evaluated on a notebook or PC.

Find out more here.

Free webinar!

Dr. Ingo Nickel, Head of Market Management Chemical Industry at FLEXIM, will present the new flowmeter series in a public webinar on Sept. 23, 2021 (two sessions at 9 a.m. and 4 p.m. CET). Please register here.

Contact:

Jörg Sacher   ▪   PR / Communications

FLEXIM GmbH  ▪   ( +49 30 93 66 76 71 09   ▪   jsacher@flexim.de   ▪   www.flexim.com

Related Images

Image 1: FLUXUS FG 831

This content was issued through the press release distribution service at Newswire.com.

Attachment

WillScot Mobile Mini Holdings to Participate in the Morgan Stanley Virtual Laguna Conference

PHOENIX, Sept. 10, 2021 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini Holdings” or the “Company”) (Nasdaq: WSC), a North American leader in turnkey modular space and portable storage solutions, today announced that Tim Boswell, President & Chief Financial Officer, will be presenting and hosting private meetings during the 2021 Morgan Stanley Virtual Laguna Conference on Tuesday, September 14, 2021. The presentation will take place at 2:15 p.m. Eastern Daylight Time.

About WillScot Mobile Mini Holdings

WillScot Mobile Mini Holdings trades on the Nasdaq stock exchange under the ticker symbol “WSC.” Headquartered in Phoenix, Arizona, the Company is a leading business services provider specializing in innovative flexible workspace and portable storage solutions. WillScot Mobile Mini services diverse end markets across all sectors of the economy from a network of approximately 275 branch locations and additional drop lots throughout the United States, Canada, Mexico, and the United Kingdom.

Additional Information and Where to Find It

Additional information can be found on the company’s website at www.willscotmobilemini.com

Contact Information

Investor Inquiries:

Nick Girardi
nick.girardi@willscotmobilemini.com

Media Inquiries:

Scott Junk
scott.junk@willscotmobilemini.com

GA-ASI Flies UAS in the Canadian Arctic

Featured Image for General Atomics Aeronautical Systems, Inc.

Featured Image for General Atomics Aeronautical Systems, Inc.

SAN DIEGO, Sept. 10, 2021 (GLOBE NEWSWIRE) — In a flight that originated from its Flight Test and Training Center (FTTC) near Grand Forks, N.D., General Atomics Aeronautical Systems, Inc. (GA-ASI) flew a company-owned MQ-9A “Big Wing” configured Unmanned Aircraft System north through Canadian airspace past the 78th parallel.

A traditional limitation of long-endurance UAS has been their inability to operate at extreme northern (and southern) latitudes, as many legacy SATCOM datalinks can become less reliable above the Arctic (or below the Antarctic) Circle – approximately 66 degrees north. At those latitudes, the low-look angle to geostationary Ku-band satellites begins to compromise the link. GA-ASI has demonstrated a new capability for effective ISR operations by performing a loiter at 78.31° North, using Inmarsat’s L-band Airborne ISR Service (LAISR).

The flight over Haig-Thomas Island, in the Canadian Arctic, demonstrated the UAS’s flexibility by operating at very high latitudes. The flight, which took off on Sept. 7 and returned to the FTTC on Sept. 8, was conducted with cooperation from the Federal Aviation Administration, Transport Canada and Nav Canada.

Covering 4,550 miles in 25.5 hours, it was one of the longest range flights ever flown by a company MQ-9. The flight was performed under an FAA Special Airworthiness Certificate and a Transport Canada Special Flight Operations Certificate.

GA-ASI partnered with Inmarsat Government, a leading provider of secure, global mission-critical telecommunications to the U.S. government in the design, acceptance testing and deployment of an enhanced satellite communications (SATCOM) system. The SATCOM was one of the key enablers of the flight and consisted of a GA-ASI-designed L-band High Data Rate system, as well as an Inmarsat Low Data Rate backup datalink that could retain the aircraft’s link to the Ground Control Station even when operating in the high-latitude environment.

“As the global leader in UAS, we have enabled our UAS to operate in Arctic regions, over land and sea, where effective C2 and ISR-data transfer was previously not feasible,” said Linden Blue, GA-ASI CEO. “As new customers come online, we want our aircraft to be able to provide them with the high data rate surveillance and high endurance that our aircraft are known for and be able to do so in any environment.”

GA-ASI coordinated between domestic and international airspace authorities for the flight. This is part of the company’s ongoing Airspace Integration initiative, designed to demonstrate how UAS can fly safely across international borders, in controlled airspace, and in this case, to extreme northern latitudes.

“At Inmarsat Government, we take pride in delivering SATCOM solutions that empower our customers’ current and future UAS missions around the world, even in the most challenging environments,” said Tom Costello, Chief Commercial Officer, Inmarsat Government. “We are proud to partner with organizations like GA-ASI that enable the government and military to enhance their use of UAS and deliver the SATCOM required for full situational awareness and mission success.”

MQ-9A has unmatched operational flexibility, and when modified with the Big Wing, it has endurance over 43 hours, speeds of 220 KTAS, and can operate at altitude of up to 45,000 feet. It has a 4,800 pound (2,177 kilogram) payload capacity that includes 4,000 pounds (1,814 kilograms) of external stores. It provides long-endurance, persistent surveillance capabilities, with Full-Motion Video and Synthetic Aperture Radar/Moving Target Indicator/Maritime Radar. An extremely reliable aircraft, MQ-9A Big Wing is equipped with a fault-tolerant flight control system and triple redundant avionics system architecture. It is engineered to meet and exceed manned aircraft reliability standards.

GA-ASI’s newest models, the MQ-9B SkyGuardian® and SeaGuardian®, represent the next generation of UAS, having demonstrated airborne endurance of more than 40 hours, automatic takeoffs and landings under SATCOM-only control, and a Detect and Avoid system. Its development is the result of a company-funded effort to deliver a UAS that can meet the stringent airworthiness certification requirements of various military and civil authorities.

About GA-ASI

General Atomics-Aeronautical Systems, Inc. (GA-ASI), an affiliate of General Atomics, is a leading designer and manufacturer of proven, reliable remotely piloted aircraft (RPA) systems, radars, and electro-optic and related mission systems, including the Predator® RPA series and the Lynx® Multi-mode Radar. With more than seven million flight hours, GA-ASI provides long-endurance, mission-capable aircraft with integrated sensor and data link systems required to deliver persistent flight that enables situational awareness and rapid strike. The company also produces a variety of ground control stations and sensor control/image analysis software, offers pilot training and support services, and develops meta-material antennas. For more information, visit www.ga-asi.com.

Avenger, Lynx, Predator, SeaGuardian and SkyGuardian are registered trademarks of General Atomics Aeronautical Systems, Inc.

# # #

CONTACT:
GA-ASI Media Relations
General Atomics Aeronautical Systems, Inc.
+1 (858) 524-8101
ASI-MediaRelations@ga-asi.com

Related Images

Image 1

This content was issued through the press release distribution service at Newswire.com.

Attachment

With More Doses, Uganda Takes Vaccination Drive to Markets

KAMPALA, UGANDA – At a taxi stand by a bustling market in Kampala, Uganda’s capital, traders simply cross a road or two, get a shot in the arm and rush back to their work.

Until this week, vaccination centers were based mostly in hospitals in this East African country that faced a brutal COVID-19 surge earlier this year.

Now, more than a dozen tented sites have been set up in busy areas to make it easier to get inoculated in Kampala as health authorities team up with the Red Cross to administer more than 120,000 doses that will expire at the end of September.

“All of this we could have done earlier, but we were not assured of availability of vaccines,” said Dr. Misaki Wayengera, who leads a team of scientists advising authorities on the pandemic response, speaking of vaccination spots in downtown areas. “Right now, we are receiving more vaccines and we have to deploy them as much as possible.”

In addition to the 128,000 AstraZeneca doses donated by Norway at the end of August, the United Kingdom last month donated nearly 300,000 doses. China recently donated 300,000 doses of its Sinovac vaccine, and on Monday a batch of 647,000 Moderna doses donated by the United States arrived in Uganda.

Suddenly Uganda must accelerate its vaccination drive. The country has sometimes struggled with hesitancy as some question the safety of the two-shot AstraZeneca vaccine, which is no longer in use in Norway because of concerns over unusual blood clots in a small number of people who received it.

Africa has fully vaccinated just 3.1% of its 1.3 billion people, according to the Africa Centers for Disease Control and Prevention. Public health officials across Africa have complained loudly of vaccine inequality and what they see as hoarding in some rich countries. Soon hundreds of millions of vaccine doses will be delivered to Africa through donations of excess doses by wealthy nations or purchases by the African Union.

Africa is aiming to vaccinate 60% of the continent’s population by the end of 2022, a steep target given the global demand for doses. The African Union, representing the continent’s 54 countries, has ordered 400 million Johnson & Johnson doses, but the distribution of those doses will be spread out over 12 months because there simply isn’t enough supply.

COVAX, the U.N.-backed program which aims to get vaccines to the neediest people in the world, said this week that its efforts continue “to be hampered by export bans, the prioritization of bilateral deals by manufacturers and countries, ongoing challenges in scaling up production by some key producers, and delays in filing for regulatory approval.”

Uganda, a country of more than 44 million people, has recorded more than 120,000 cases of COVID-19, including just over 3,000 deaths, according to official figures. The country has given 1.65 million shots, but only about 400,000 people have received two doses, according to Wayengera. Uganda’s target is to fully vaccinate up to 5 million of the most vulnerable, including nurses and teachers, as soon as possible.

At the Red Cross tent in downtown Kampala, demand for the jabs was high. By late afternoon only 30 of 150 doses remained, and some who arrived later were told to come back the next day.

“I came here on a sure deal, but it hasn’t happened,” said trader Sulaiman Mivule after a nurse told him he was too late for a shot that day. “I will come back tomorrow. It’s easy for me here because I work in this area.”

Asked why he was so eager to get his first shot, he said, “They are telling us that there could be a third wave. If it comes when we are very vaccinated, maybe it will not hurt us so much. Prevention is better than cure.”

Mivule and others who spoke to the AP said they didn’t want to go to vaccination sites at hospitals because of they expected to find crowds there.

Bernard Ssembatya said he had been driving by when he spotted the Red Cross’s white tent and went in for a jab on the spur of the moment. Afterward, he texted his friends about the opportunity.

“I was getting demoralized by going to health centers,” he said. “You see a lot of people there and you don’t even want to try to enter.”

Yet, despite enthusiasm among many, some still walked away without getting a shot when they were told their preferred vaccine was not yet available.

The one-shot J&J vaccine, still unavailable in Uganda, is frequently asked for, said Jacinta Twinomujuni, a nurse with the Kampala Capital City Authority who monitored the scene.

“I tell them, of course, that we don’t have it,” she said. “And they say, ‘OK, let’s wait for it.’”

Source: Voice Of America

A Tale of 2 COVID Vaccine Clinics: Lines in Kenya, Few Takers in Atlanta

NAIROBI – Several hundred people line up every morning, starting before dawn, on a grassy area outside Nairobi’s largest hospital hoping to get the COVID-19 vaccine. Sometimes the line moves smoothly, while on other days, the staff tells them there’s nothing available and they should come back tomorrow.

Halfway around the world, at a church in Atlanta in the U.S. state of Georgia, two workers with plenty of vaccine doses waited hours Wednesday for anyone to show up, whiling away the time by listening to music from a laptop. In six hours, one person came through the door.

The dramatic contrast highlights the vast disparity around the world. In richer countries, people can often pick and choose from multiple available vaccines, walk into a site near their homes and get a shot in minutes. Pop-up clinics, such as the one in Atlanta, bring vaccines into rural areas and urban neighborhoods, but it is common for them to get very few takers.

In the developing world, supply is limited and uncertain. Just more than 3% of people across Africa have been fully vaccinated, and health officials and citizens often have little idea what will be available from one day to the next. More vaccines have been flowing in recent weeks, but the World Health Organization’s director in Africa said Thursday that the continent will get 25% fewer doses than anticipated by the end of the year, in part because of the rollout of booster shots in wealthier counties such as the United States.

Bidian Okoth said he spent more than three hours in line at a Nairobi hospital, only to be told to go home because there weren’t enough doses. But a friend who traveled to the U.S. got a shot almost immediately after his arrival there with a vaccine of his choice, “like candy,” he said.

“We’re struggling with what time in the morning we need to wake up to get the first shot. Then you hear people choosing their vaccines. That’s super, super excessive,” he said.

Okoth said his uncle died from COVID-19 in June and had given up twice on getting vaccinated because of the length of the lines, even though he was eligible because of his age. The death jolted Okoth, a health advocate, into seeking a dose for himself.

He stopped at one hospital so often on his way to work that a doctor “got tired of seeing me” and told Okoth he would call him when doses were available. Late last month, after a new donation of vaccines arrived from Britain, he got his shot.

The disparity comes as the U.S. is moving closer to offering booster shots to large segments of the population even as it struggles to persuade Americans to get vaccinated in the first place. President Joe Biden on Thursday ordered sweeping new federal vaccine requirements for as many as 100 million Americans, including private-sector employees, as the country faces the surging COVID-19 delta variant.

About 53% of the U.S. population is fully vaccinated, and the country is averaging about 145,000 new cases of COVID-19 a day, along with about 1,600 deaths, according to Johns Hopkins Coronavirus Resource Center. Africa has had more than 7.9 million confirmed cases, including more than 200,000 deaths, and the highly infectious delta variant recently drove a surge in new cases as well.

John Nkengasong, director of the Africa Centers for Disease Control and Prevention, told reporters Thursday that “we have not seen enough science” to drive decisions on when to administer booster shots.

“Without that, we are gambling,” he said, and urged countries to send doses to countries facing “vaccine famine” instead.

In the U.S., vaccines are easy to find, but some people are hesitant to get them.

At the church in northwest Atlanta, a nonprofit group offered the Johnson & Johnson and Pfizer vaccines for free without an appointment from 10:30 a.m. to 4:30 p.m. But site manager Riley Erickson spent much of the day waiting in an air-conditioned room full of empty chairs, though the group had reached out to neighbors and the church had advertised the location to its large congregation.

Erickson, with the disaster relief organization CORE, said the vaccination rate in the area was low and he wasn’t surprised by the small turnout. The one person who showed up was a college student.

“When you put the effort into going into areas where there’s less interest, that’s kind of the result,” he said. His takeaway, however, was that CORE needed to spend more time in the community.

Margaret Herro, CORE’s Georgia director, said the group has seen an uptick in vaccinations at its pop-up sites in recent weeks amid a COVID-19 surge fueled by the delta variant and the FDA’s full approval of the Pfizer vaccine. It also has gone to meatpacking plants and other work locations, where turnout is better, and it plans to focus more on those places, Herro said.

In Nairobi, Okoth believes there should be a global commitment to equity in the administration of vaccines so everyone has a basic level of immunity as quickly as possible.

“If everyone at least gets a first shot, I don’t think anyone will care if others get even six booster shots,” he said.

Source: Voice Of America